news release

Dermatologic Cosmetic Laboratories Introduces
The First System that Controls all Aspects of a Glycolic Peel.
   
Easy-to-Use Epi-Peel® System features Advanced Formulation and Controlled Dosing for Better, More Predictable Results.

FOR IMMEDIATE RELEASE
EAST HAVEN,CT – January 12, 2006 Dermatologic Cosmetic Laboratories introduces the Epi-Peel® System, a new glycolic peel system specifically designed to offer physicians a more effective, efficient and predictable way to administer professional in-office glycolic peels.

The Epi-Peel® System is available in two innovative formulations: Level 1 (40% active) and Level II (70% active). The Level I (40% active) formulation introduces a clinically active level of willowherb extract, which DCL scientists have identified and incorporated into the formula to help soothe and calm the skin while the beneficial effects of the peel are taking effect. The formula is also a gel-like consistency designed for easier spreadability and even application. The Level II (70% active) formulation includes the most effective topical anti-oxidant, Vitamin C, in a highly stable water soluble form- magnesium ascorbyl phosphate. The addition of this ingredient helps even skin tone and maximize efficacy of the glycolic peel. 

Each system comes in a convenient 50 application kit, which includes the glycolic peel solution, a dose controlling measuring cup, special cotton applicators with a specific weight and density and simple 3-step instructions that makes administering the peels easier than ever. Dose, concentration and timing are controlled to provide reproducible and consistent results.

The 3-step systems each come with clear, easy to follow directions to “prep, peel and neutralize” measured amounts of glycolic solution with detailed treatment durations and recommended intervals to make the results more precise and the process easier than ever before.

“The key to an effective glycolic peel is CONTROL. Recent studies have demonstrated the relationship between the control of pH, pka (3.82), percent free acid and efficacy and irritation. DCL has used these documented studies to formulate the Epi-Peel® System, the first Glycolic System to control all aspects of a chemical peel this scientifically from formulation through application. The addition of willowherb extract further enhances an ideal formulation,” stated Neal Schultz, MD, DCL’s Sr. Vice President and Clinical Medical Director.

“For years, doctors have had to do an unfortunate amount of guesswork when working with glycolic peels,” said Truitt Bell, President and CEO of Dermatologic Cosmetic Laboratories. “We took a comprehensive look at glycolic peels from every angle- formulation, dosage, timing, ease-of-use – to create a new, more thought-out generation of glycolic products for our clients.”


About Dermatologic Cosmetic Laboratories
Dermatologic Cosmetic Laboratories produces high performance, non-prescription formulations for face, hair, body and sun protection, for direct dispensing by physicians. DCL formulates and manufactures at its on-site, FDA/OTC registered facility. The company is best known for its clinically proven Anti-Aging System, Acne Healing System and its AHA “Step Up” System as well as their consultative support for first-time as well as experienced dispensing physicians. 

The Epi-Peel® System, Level 1 and Level 2, is currently available through Dermatologic Cosmetic Laboratories. For more information about DCL Skincare products please visit the website at www.dclskincare.com or call 1-800-552-5060.

###

DCL Contact:
Lindsay Germano
Marketing Manager
203-466-4636
lgermano@dclskincare.com